Skip to main content
TipRanks
Go Ultimate75% OFF

CARE Ratings Ltd (CARERATING) AI Stock Analysis

5 Followers
IN:CARERATING

CARE Ratings Ltd

(NSE:CARERATING)

Select Model
Rating:76Outperform
Price Target:INR 1,769.00â–²(11.26% Upside)
Action:reiterated
Date:11/18/26

Strong financial performance with revenue expansion and low leverage is the primary driver, tempered by weak technical signals from price action below moving averages.

Positive Factors
Revenue and Profit GrowthSteady multi-year revenue compounding and consistent net-income growth indicate durable demand for CARE Ratings’ credit opinions and analytical services. The 2026 acceleration strengthens the company’s ability to reinvest, expand relationships, and build earnings over the next several quarters.
Negative Factors
Margin CompressionThe sharp decline in gross and operating margins shows that rising revenue has not translated into equally stable operating economics. If the pressure reflects a persistent cost or service-mix change, it could reduce earnings growth and weaken the benefit of future top-line expansion.

CARE Ratings Ltd (CARERATING) vs. iShares MSCI India ETF (INDA)

-20%-10%0%10%20%30%IN:CARERATING+7.88%INDA-4.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 47.22B
Dividend Yield
1.51%
Average Volume (3M)
7,499
Price to Earnings (P/E)
24.8
Beta (1Y)
0.47
Revenue Growth
18.86%
EPS Growth
25.69%
Country
India
Employees
608
Sector
General
Sector Strength
55
Industry
Financial - Data & Stock Exchanges

CARE Ratings Ltd Business Overview & Revenue Model

Company Description

CARE Ratings Limited operates as a prominent credit rating agency, delivering a wide spectrum of rating and grading solutions across India, Mauritius, and Nepal. Its principal services involve assessing various debt instruments, including bonds, debe...

How the Company Makes Money

CARE Ratings primarily generates revenue by providing credit rating and associated analytical services. Its core revenue stream is fees charged for assigning and monitoring ratings on debt instruments and issuers—such as corporate bonds, bank facilit...

CARE Ratings Ltd Financial Statement Overview

Summary

Consistent revenue growth to 4.73 billion, strong balance sheet with low debt-to-equity under 0.03, and robust operating cash flow reaching 2.53 billion support solid financial health.

Income Statement

85Very Positive

Balance Sheet

90Very Positive

Cash Flow

88Very Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue5.19B4.73B4.02B3.32B2.79B2.47B
Gross Profit2.49B2.40B2.29B1.49B1.55B1.35B
EBITDA2.49B2.01B2.06B1.59B1.37B1.07B
Net Income1.93B1.71B1.37B1.01B835.29M751.08M
Balance Sheet
Total Assets11.96B11.05B9.58B8.42B7.70B7.27B
Cash, Cash Equivalents and Short-Term Investments2.95B1.50B6.41B6.26B5.65B5.21B
Total Debt241.22M261.84M237.69M195.54M174.78M89.13M
Total Liabilities1.82B1.62B1.42B1.17B905.77M745.98M
Stockholders Equity10.02B9.32B8.06B7.17B6.72B6.47B
Cash Flow
Free Cash Flow02.44B1.08B817.10M707.36M490.20M
Operating Cash Flow02.53B1.23B908.82M822.42M680.03M
Investing Cash Flow0-2.00B-584.28M-390.66M128.80M-273.18M
Financing Cash Flow0-593.33M-539.96M-629.55M-633.31M-351.38M

CARE Ratings Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price1589.90

Price Trends

50DMA1604.81Negative
100DMA1639.95Negative
200DMA1615.62Negative

Market Momentum

MACD-3.89Negative
RSI49.07Neutral
STOCH50.49Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CARERATING, the sentiment is Negative. The current price of 1589.90 is below the 20-day moving average (MA) of 1596.13, below the 50-day MA of 1604.81, and below the 200-day MA of 1615.62, indicating a bearish trend. The MACD of -3.89 indicates Negative momentum. The RSI at 49.07 is Neutral, neither overbought nor oversold. The STOCH value of 50.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:CARERATING.

CARE Ratings Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:CARERATING against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:CARERATINGIN:CARERATING76OutperformINR 47.91B24.78―1.51%18.86%25.69%
IN:ICRAIN:ICRA70OutperformINR 42.94B21.45―2.36%31.17%6.13%
IN:CRISILIN:CRISIL69NeutralINR 303.53B33.92―1.54%23.83%19.56%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-20%-10%0%10%IN:CARERATINGIN:CRISILIN:ICRADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:CARERATING and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:CARERATINGCARE Ratings Ltd1589.90102.386.88%
IN:CRISILCRISIL Limited4150.50-302.82-6.80%
IN:ICRAICRA Limited4448.85-1477.06-24.93%

CARE Ratings Ltd Corporate Events

CARE Ratings Cancels Scheduled Analyst and Investor Meet

Sep 3, 2026

CARE Ratings Limited has informed stock exchanges that its scheduled analyst and institutional investor meeting, planned for the evening of 3 September 2026, has been cancelled due to exigencies. The company emphasized that this disclosure is being m...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026